Application of Porous Nanomaterials for Sustained and Targeted Drug Release

Abstract:

Patients must take significant doses of drugs to acquire the therapeutic effects required for disease therapy due to the absence of selectivity and accessibility of medicinal molecules. Drugs contain a range of drug carriers that are available to transport therapeutic chemicals to the targeted issues in the body. Mesoporous materials are choice for overcoming the aforementioned issues and producing effects in a predictable and long-term way. Because of its chemical characteristics, thermal stability, & biocompatibility, mesophoric nanoparticles are commonly utilized as release reagents. The innovative silica mesophore technology allows for efficient drug loading and administration after the target site has been reached. The additives used to manufacture MSNs can affect the property of mesoporous materials, including pore width, porosity, drug load, and surface characteristics. The need for an active surface provides for surface treatment as well as the coupling of therapeutic substances. They are widely employed in the bio-medical industry for diagnosis, target medication administration, bio-sensing, cellular absorption, and so on. The purpose of this study is, to sum up the existing level of information about mesoporous nanomaterials and their applications in diverse healthcare sectors.

• Periodical: Advances in Science and Technology (Volume 117)
• Pages: 105-110
• DOI: https://doi.org/10.4028/p-b2484c
• Online since: August 2022
• Authors: Mohammad Javed Ansari, Aziz Unnisa*, Anshul Singh, Devvret Verma, Rahul Kanaoujiya, Jose Luis Arias Gonzales
• Keywords: Drug Delivery, Porous Drug Carrier, Sustained, Targeted

References

[1] A. Swami, S. Jinjun, G. Suresh, R. A. Votruba, K, Nagesh, C. O. Farokhzad. Nanoparticles for targeted and temporally controlled drug delivery. In, Svenson S, Prud'homme RK, editors. Multifunctional Nanoparticles for Drug Delivery, Applications, Imaging, Targeting, and Delivery, Nanostructure Science Technology. Bostan, USA, Springer, 2012. pp.9-25.

DOI: 10.1007/978-1-4614-2305-8_2

[2] V.J. Mohanraj, Y.Chen. Nanoparticle, A review. Trop J Pharm Res 5, (2006), 561-573.

[3] K. Sooyeon, R. K. Singh, C. Wojciech. Silica-based mesoporous nanoparticles for controlled drug delivery. J Tissue Eng 4, (2013), 1-35.

[4] L. Brannon-Peppas. Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug delivery. Int J Pharm 116, (1995), 1-9.

DOI: 10.1016/0378-5173(94)00324-x

[5] Kresge CT, Leonowicz ME, Roth WJ. Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism. Nature 359, (1992), 710-2.

DOI: 10.1038/359710a0

[6] Y.A. Shchipunov, Y.V. Burtseva, T. Y Karpenko, N.M. Shevchenko, T.N. Zvyagintseva, M. Starikayasss, et al. Highly efficient immobilization of endo-1, 3-beta-d-glucanases (laminarinases) from marine mollusks in novel hybrid polysaccharide-silica nanocomposites with regulated composition. J Mol Catal 40 (2006), 16-23.

DOI: 10.1016/j.molcatb.2006.02.002

[7] Y. Klichko, M. Liong, E. Choi, S. Angelos, A.E. Nel, E. Stoddart, et al. Mesostructured silica for optical functionality, nanomachines, and drug delivery. J Am Ceram Soc 92, (2009), S2-10.

DOI: 10.1111/j.1551-2916.2008.02722.x

[8] C. Tourne-Peteilh, S. Begu, D.A. Lerner, A. Galarneau, U. Lafont, J.M. Devoisselle. Sol-gel one-pot synthesis in soft conditions of mesoporous silica materials ready for drug delivery system. J Solgel Sci Technol 61, (2012), 455-462.

DOI: 10.1007/s10971-011-2646-x

[9] M. Liong, J. Lu, M. Kovochich, T. Xia, S.G. Ruehm, A.E. Nel, et al. Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. ACS Nano 2, (2008), 889-896.

DOI: 10.1021/nn800072t

[10] C. Hongmin, Z. Zipeng, X. Jin. Label-free luminescent mesoporous silica nanoparticles for imaging and drug delivery. Theranostic 3, (2013), 650-657.

[11] J. Xie, S. Lee, X. Chen. Nanoparticle-based theranostic agents. Adv Drug Deliv Rev 62, (2012), 1064-1079.

[12] X. Lin, J. Xie, G. Niu, F. Zhang, H. Gao, M. Yang, et al. Chimeric ferritin nanocages for multiple function loading and multimodal imaging. Nano Lett 11, (2011), 814-819.

DOI: 10.1021/nl104141g

[13] C. Fruijtier-Pölloth. The toxicological mode of action and the safety of synthetic amorphous silica-a nanostructured material. Toxicology 294, (2012), 61-79.

DOI: 10.1016/j.tox.2012.02.001

[14] J.L. Vivero-Escoto, J. Luis. Surface functionalized mesoporous silica nanoparticles for intracellular drug delivery. Diss Abstr Int 71, (2009), 621-638.

DOI: 10.31274/etd-180810-1758

[15] P. Selvam, S.K. Bhatia, C.G. Sonwane. Recent advances in processing and characterization of periodic mesoporous MCM-41 silicate molecular sieves. Ind Eng Chem Res 40, (2001), 3237-3261.

DOI: 10.1021/ie0010666

[16] M. Gary-Bobo, O. Hocine, D. Brevet, M. Maynadier, L. Raehm, S. Richeter, et al. Cancer therapy improvement with mesoporous silica nanoparticles combining targeting, drug delivery and PDT. Int J Pharm 423, (2012), 509-515.

DOI: 10.1016/j.ijpharm.2011.11.045

[17] H.H. Yiu, P.A. Wright. Enzymes supported on ordered mesoporous solids, A special case of an inorganic-organic hybrid. Mater Chem 15, (2005), 3690-3700.

DOI: 10.1039/b506090g

[18] B.G. Trewyn, I.I. Slowing, S. Giri, H.T. Chen, V.S. Lin. Synthesis and functionalization of a mesoporous silica nanoparticle based on the sol-gel process and applications in controlled release. Acc Chem Res 40, (2007), 846-853.

DOI: 10.1021/ar600032u

[19] S. Radin, P. Ducheyne, T. Kamplain , B. H. Tan. Silica sol-gel for the controlled release of antibiotics. I. Synthesis, characterization, and in vitro release. J Biomed Mater Res 57, (2001), 313-320.

DOI: 10.1002/1097-4636(200111)57:2<313::aid-jbm1173>3.0.co;2-e

[20] A. Rambabu. Novel synthesis, structure and functions of mesoporous silica materials. Uppsala, Acta Universitatis Upsaliensis, 2010. pp.13-24.

[21] A. Firouzi, D. Kumar, L. M. Bull, T. Besier, P. Sieger, Q. Huo, et al.nCooperative organization of inorganic-surfactant and biomimetic assemblies. Science 267, (1995), 1138-1143.

DOI: 10.1126/science.7855591

[22] R.E. Yanes, F. Tamanoi. Development of mesoporous silica nanomaterials as a vehicle for anticancer drug delivery. Ther Deliv 3, (2012), 389-404.

DOI: 10.4155/tde.12.9

[23] J. Lu, M. Liong, J.I. Zink, F. Tamanoi. Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs. Small 3, (2007), 1341-1346.

DOI: 10.1002/smll.200700005

[24] X. Huang, L. Li, T. Liu, N. Hao, H. Liu, D. Chen, et al. The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo. ACS Nano 5, (2011), 5390-9.

DOI: 10.1021/nn200365a

[25] Portin L. Layer by Layer Assembly of the Polyelectrolyte on Mesoporous Silicon. Biosciences, University of Eastern Finland, Finland, 2012. pp.1-59.

[26] Bergman L, Kankaanpaa L, Tiitta S, Duchanoy A, Li L, Heino J, et al. Intracellular degradation of multilabeled poly (ethyleneimine) - Mesoporous silica-silica nanoparticles, Implications for drug release. Mol Pharm 10, (2013), 1795-1803.

DOI: 10.1021/mp3005879

[27] T. Yu, A. Malugin, H. Ghandehari. Impact of silica nanoparticles design on cellular toxicity and haemolytic activity. ACS Nano 5, (2011), 5717-5728.

DOI: 10.1021/nn2013904

[28] J. Zhang, Z.F. Yuan, Y. Wang, W.H. Chen, G.F. Luo, S.X. Cheng, et al. Multifunctional envelope-type mesoporous silica nanoparticles for tumor-triggered targeting drug delivery. J Am Chem Soc 135, (2013), 5068-5073.

DOI: 10.1021/ja312004m

[29] M. Vallet-Regi, I. Izquierdo-Barba, M. Colilla. Structure and functionalization of mesoporous bioceramics for bone tissue regeneration and local drug delivery. Philos Trans R Soc A 370, (2012), 1400-1421.

DOI: 10.1098/rsta.2011.0258

[30] H. Du, P.D. Hamilton, M.A. Reilly, A. d'Avignon, P. Biswas, N. Ravi. A facile synthesis of highly water-soluble, core-shell organo-silica nanoparticles with controllable size via sol-gel process. J Colloid Interface Sci 340, (2009), 202-208.

DOI: 10.1016/j.jcis.2009.08.032

[31] S.M. Janib, A.S. Moses, J.A. MacKay. Imaging and drug delivery using theranostic nanoparticles. Adv Drug Deliv Rev 62, (2010), 1052-1063.

DOI: 10.1016/j.addr.2010.08.004

[32] L.S. Wang, L.C. Wu, S.Y. Lu, L.L. Chang, I.T. Teng, C.M. Yang. Bio functionalized phospholipid-capped mesoporous silica nanoshuttles for targeted drug delivery, Improved water suspensibility and decreased nonspecific protein binding. ACS Nano 4, (2010), 4371-4379.

DOI: 10.1021/nn901376h

[33] D. Tarn, C.E. Ashley, M. Xue, E.C. Carnes, J.I. Zink, C.J. Brinker. Mesoporous silica nanoparticle nanocarriers, Biofunctionality and biocompatibility. Acc Chem Res 46, (2013), 792-801.

DOI: 10.1021/ar3000986

[34] D. Singh, J.M. McMillan, X.M. Liu, H.M. Vishwasrao, A.V. Kabanov, M. Sokolsky-Papkov, et al. Formulation design facilitates magnetic nanoparticle delivery to diseased cells and tissues. Nanomedicine (Lond) 9, (2014), 469-485.

DOI: 10.2217/nnm.14.4